The government had already decided that storage limits should be extended from ten years to twelve. It is unclear if any further change has been made to the regulations following this consultation.

Report published 1 October 2020. No mention of breast cancer screening or AgeX.

Report of strategy published March 2020. The EMA clearly had its own agenda and much of what is in the report reflects this. There is some mention of medical device regulation, e.g. where the report says that they wish to "[c]reate a process to consult medical device authorities and/or notified bodies (as applicable) for device-related aspects throughout the product lifecycle, including post-authorisation safety related events".

Awaited. No date of publication of outcome mentioned on website but there is an invitation to sign up for updates.

Interim report published May 2019. No mention of concerns about breast cancer screening or the shortcomings of the AgeX Trial.

Awaited. Email sent to their office on 7th September 2019 asking for an update.